MMedXYNews
Ask AIHomeVideos
MedXY AI/MedXY News/Section: Hematology-Oncology
Hematology-Oncology

Breaking the Immortality of Cancer Cells: Israel’s Groundbreaking RNA-Targeting Drug

MedXY Editorial TeamNov 10, 2025
cancer

Introduction: The Challenge of Cancer Cell Immortality

Cancer, a leading cause of death worldwide, remains a formidable challenge largely due to the unique ability of cancer cells to evade the natural limits of cellular life. Unlike normal cells, which have a built-in “expiration date,” cancer cells find ways to become virtually immortal, continuously dividing and growing unchecked. This limitless proliferation is underpinned by mechanisms that preserve the integrity of chromosome ends, known as telomeres. Traditional cancer treatments have largely focused on protein targets, but a pioneering Israeli research team has developed a revolutionary approach that targets RNA molecules controlling this immortality at a more fundamental level.

The Biology Behind Cellular Aging and Cancer Cell Longevity

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Estimating the National Impact of Severe Hemolytic Disease of the Fetus and Newborn in the United States

Hematology-OncologyNov 4, 2026

Unraveling Donor Cell-Derived Hematologic Neoplasms: Insights from Spanish Transplant Centers

Hematology-OncologyNov 3, 2026

Long-Term Outcomes of Fixed Low versus Moderate Hydroxyurea Dosing in Sickle Cell Stroke Prevention: Insights from the SPRINT Cohort

Hematology-OncologyNov 2, 2026
Loading comments...

Most read

  1. 01Intimate Health

    Five Benefits for Women Continuing Sexual Activity After Menopause

  2. 02Intimate Health

    Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It

  3. 03Nursing & care

    How often should a couple have sex?

  4. 04Cardiology

    Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval

  5. 05General Surgery

    Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.

© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story